Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pill under microscope lens

Restricting what is allowed on prescription in England: views from healthcare professionals and patient groupsSubscription

By

We ask healthcare professionals across primary care and patient groups for their thoughts on NHS England’s decision to review what GPs are allowed to prescribe.

Scientists pushing pills around model human body

Rare but not forgotten: why drug appraisal methods must be updated to consider treatments for rare diseasesSubscription

By

The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare diseases being left out in the cold.

Andy Gray (left) and Hans Hogerzeil

Q&A: How to ensure access to essential medicines for those in low and middle-income countriesSubscription

By

Andy Gray and Hans Hogerzeil, co-chairs of the The Lancet Commission on Essential Medicines, discuss the analysis on the cost of providing essential medicines to people in low and middle-income countries.

Illustration of three people sweeping a bunch of leaves on a very windy day

Why legal action is not the best way to address the community pharmacy funding crisis in England

By Terry Maguire

As pharmacy contractors in England suffer budget cuts and their leaders instigate legal action, Northern Ireland pharmacy contractor Terry Maguire argues why this might not be a good idea and what English contractors might learn from their Celtic cousins.

Shanelle Hall, Director of Supply Division, UNICEF

A breakthrough in lowering the price of vaccines to increase access to childrenSubscription

By

Shanelle Hall from UNICEF discusses the breakthrough pentavalent vaccine three-year tender with six vaccine suppliers.

Donald M. Berwick

Q&A: Invest in safety and make savings overall — interview with Don BerwickSubscription

By

The author of the 2013 report which looked at patient safety in the NHS after the Mid Staffordshire Hospital scandal speaks to Jenny Bryan to share his thoughts on whether progress has been made.

Illustration showing alarm due to rise of antimicrobial resistant bacteria from biocides and heavy metals

How chemicals and heavy metals contribute to antimicrobial resistanceSubscription

By

Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.

Illustration of legal scales

Why pharmacists need to re-evaluate what information they provide to patientsSubscription

By ,

Previous court cases concerning informed consent of treatment have raised questions about what consent means in relation to pharmacists, medicines and prescribing.

From left (top), Tedros Adhanom Ghebreyesus, Flavia Bustreo, Philippe Douste-Blazy, (bottom) David Nabarro, Sania Nishtar and Miklós Szócska

Q&A: WHO director-general candidates’ views on global healthSubscription

By

Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.

Donald Trump during his acceptance speech as the Republican candidate for the US presidency

What impact president-elect Donald Trump will have on the US healthcare systemSubscription

By

William Seligman takes a look at what might happen to the US healthcare system and pharma under a Trump presidency.

Maree Todd, member of the Scottish Parliament and pharmacist

Q&A: From pharmacy to the Scottish Parliament — interview with MSP Maree ToddSubscription

By

Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.

Illustration of a person cutting a pharmacy price tag

Q&A: Community pharmacy funding cuts in England – views from the front lineSubscription

By

In light of the government’s intention to cut funding for the sector and reform the remuneration structure, we asked four people from four different community pharmacy backgrounds to share their views.

Illustration showing that healthcare professionals and organisations must talk in order to get the best value for money when it comes to NHS funding

UK drug funding framework needs an overhaul to ensure the right areas are being prioritisedSubscription

By ,

If the NHS is to get value for money from medicines, it needs to consider what the UK population values and where its priorities lie.

Tim Evans is the senior director of health, nutrition and population at the World Bank Group

Q&A: World Bank warns that inaction on antimicrobial resistance could increase healthcare costs in developing countriesSubscription

By

Tim Evans from the World Bank Group talks about new research that shows how inaction on antimicrobial resistance could wipe out decades of healthcare gains and dramatically increase healthcare costs in developing countries.

Illustration showing the two sides of clinical pharmacy: medicines optimisation and patient care and well-being

Defining clinical pharmacy: a new paradigm Subscription

By , ,

Amid the rapid change and evolution of pharmacy, now is the time to redefine what clinical pharmacy means.

Paul Gallagher, head of the Royal College of Surgeons in Ireland’s School of Pharmacy

Q&A: From training surgeons in Ireland to providing healthcare education internationallySubscription

By

Paul Gallagher, head of the school of pharmacy at the Royal College of Surgeons in Ireland, speaks to Benedict Lam about how the royal college focus on education and training led to the expansion of its provision of healthcare education in Ireland and beyond.

Pharmacy research in the dictionary

Time to redefine pharmacy researchSubscription

By

There is no universal definition of pharmacy research, and this may be one of the reasons for poor quality research in the sector.

Nicola Magrini, secretary of the WHO expert committee on the selection and use of essential medicines

Q&A: Increasing global access to medicines for non-communicable diseasesSubscription

By

Nicola Magrini from the World Health Organization discusses improving access to affordable medicines for non-communicable diseases and warns that treatments for cancer lag behind.

Map showing connection points

High street pharmacies and opticians should work together to help manage minor eye conditions

By

Pharmacists and opticians should work together to better manage patients with dry eye within primary care, with one local scheme serving as a model for pharmacists to refer patients to opticians when necessary.

Hospital pharmacists working in office

Non-patient facing roles in hospital pharmacy are just as vital as patient facing onesSubscription

By

Roles such as procurement are important in hospital pharmacy services and should not be brushed aside.

More comment

Illustration of a hand putting vote in ballot box

It’s RPS national board election time againSubscription

By Alex MacKinnon

Alex MacKinnon, interim chief executive of the Royal Pharmaceutical Society, makes a plea for members to use their vote in the 2017 national board elections.

Mair Davies, RPS director for Wales

RPS director for Wales: 'There’s a collaborative approach to everything in Wales'

By

The Royal Pharmaceutical Society (RPS) Welsh Pharmacy Board launched its manifesto in November 2015. Mair Davies, director for RPS Wales, talks to Julia Robinson about progress made since the launch, and her objectives for 2017 and beyond.

Robbie Turner, new Royal Pharmaceutical Society (RPS) director for England

RPS director for England: 'Let's make sure pharmacists feel supported and invigorated'

By

New RPS director for England, Robbie Turner, tells Julia Robinson about his plans for 2017 and how he hopes his experience as chief executive of Community Pharmacy West Yorkshire will help him achieve his goals.

Alex MacKinnon, director for the Royal Pharmaceutical Society (RPS) Scotland

RPS director for Scotland: '2017 will be a year of opportunity rather than challenge'Subscription

By

Alex MacKinnon, director for the Scotland at the Royal Pharmaceutical Society (RPS), tells Julia Robinson what 2017 will mean for pharmacists in Scotland and how RPS Scotland plans to embrace new opportunities on behalf of the profession.

Helen Gordon is departing as chief executive of the Royal Pharmaceutical Society

Q&A: Farewell to RPS chief executive, Helen GordonSubscription

By

After seven years in the pharmacy world, Helen Gordon is departing as chief executive of the Royal Pharmaceutical Society to enter pastures new at the Royal Society of Medicine. Here, she talks to Julia Robinson about her proudest moments and what advice she would give to her successor. 

Linked paper dolls symbolising a united workforce

Pharmacy needs global professional standards for education and workforce developmentSubscription

By , Ian Bates

Catherine Duggan, director of professional development at the Royal Pharmaceutical Society (RPS) and Ian Bates, education adviser to the RPS English Pharmacy Board, discuss the importance of developing a global standard of education and training for pharmacists.

Simon Redman, director of finance at the Royal Pharmaceutical Society (RPS)

Q&A: An insight into the finances of the Royal Pharmaceutical SocietySubscription

By

The 2017 Royal Pharmaceutical Society (RPS) budget, agreed in November 2016, includes a financial surplus of £5,000 before interest. Here Simon Redman, director of finance at the RPS, talks to Julia Robinson about how the RPS has recovered from last year’s budgeted loss of £1.5m and what plans are being made to improve services and engage with members in the coming year. 

Doctor speaking to patient and social worker taking an elderly woman's blood pressure

Health and social care need to be better integratedSubscription

By

Sandra Gidley, chair of the RPS English Pharmacy Board, makes the case for the integration of health and social care funding and explains why pharmacists are needed across the entire health and social care system and at all levels of the NHS.

Imagery of mental illness: woman sits on stairs looking out to sea

What can pharmacists do to improve the physical health of people with mental illness?Subscription

By , Dolly Sud

David Branford, member of the Royal Pharmaceutical Society (RPS) English Pharmacy Board, and Dolly Sud, specialist mental health pharmacist Leicestershire Partnership NHS Trust, explain the importance of the role of pharmacists in improving the physical well-being of patients with severe mental illness.

Illustration showing icons on long-term conditions and pharmacy

Pharmacists can help improve the care of patients with long-term conditions across Great BritainSubscription

By , Suzanne Scott-Thomas, John McAnaw

On 3 November 2016, the RPS launched its campaign on long-term conditions. Here, the chairs of the three RPS national pharmacy boards highlight the significance of the campaign and how it needs to be actioned in their respective countries. 

Your RPS

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs

More jobs